Literature DB >> 12702192

Bloodless medicine: clinical care without allogeneic blood transfusion.

Lawrence T Goodnough1, Aryeh Shander, Richard Spence.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12702192     DOI： 10.1046/j.1537-2995.2003.00367.x

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  15 in total

Review 1.  Transfusion of post-operative shed blood: laboratory characteristics and clinical utility.

Authors:  M Muñoz; J J García-Vallejo; M D Ruiz; R Romero; E Olalla; C Sebastián
Journal:  Eur Spine J       Date:  2004-05-08       Impact factor: 3.134

2.  Bloodless cancer treatment results of patients who do not want blood transfusion: single center experience of 77 cases.

Authors:  Sung Yong Oh; Sung-Hyun Kim; Hyuk-Chan Kwon; Suee Lee; Kyeong Hee Kim; Kyung A Kwon; Jong-Hwan Lee; Kyu-Yeol Lee; Hyo-Jin Kim
Journal:  Support Care Cancer       Date:  2009-10-20       Impact factor: 3.603

3.  Preanesthetic Assessment of the Jehovah's Witness Patient.

Authors:  Eric S Lin; Alan D Kaye; Amir R Baluch
Journal:  Ochsner J       Date:  2012

Review 4.  Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges.

Authors:  Evan M Bloch; Marion Vermeulen; Edward Murphy
Journal:  Transfus Med Rev       Date:  2011-08-26

5.  Iron supplementation for postoperative anaemia following major paediatric orthopaedic surgery.

Authors:  Kelvin K W Lau; Murali M Utukuri; Manoj Ramachandran; David H A Jones
Journal:  Ann R Coll Surg Engl       Date:  2007-01       Impact factor: 1.891

6.  The promise of next generation colloids.

Authors:  Ben C Creagh-Brown; Timothy W Evans
Journal:  Crit Care       Date:  2008-05-14       Impact factor: 9.097

Review 7.  Non-blood medical care in gynecologic oncology: a review and update of blood conservation management schemes.

Authors:  Maria Simou; Nikolaos Thomakos; Flora Zagouri; Antonios Vlysmas; Nikolaos Akrivos; Dimitrios Zacharakis; Christos A Papadimitriou; Meletios-Athanassios Dimopoulos; Alexandros Rodolakis; Aris Antsaklis
Journal:  World J Surg Oncol       Date:  2011-11-03       Impact factor: 2.754

8.  Ferric carboxymaltose with or without erythropoietin for the prevention of red-cell transfusions in the perioperative period of osteoporotic hip fractures: a randomized contolled trial. The PAHFRAC-01 project.

Authors:  Máximo Bernabeu-Wittel; Reyes Aparicio; Manuel Romero; José Murcia-Zaragoza; Rafael Monte-Secades; Clara Rosso; Abelardo Montero; Alberto Ruiz-Cantero; María Melero-Bascones
Journal:  BMC Musculoskelet Disord       Date:  2012-02-21       Impact factor: 2.362

9.  Survival time in severe hemorrhagic shock after perioperative hemodilution is longer with PEG-conjugated human serum albumin than with HES 130/0.4: a microvascular perspective.

Authors:  Judith Martini; Pedro Cabrales; Ananda K; Seetharama A Acharya; Marcos Intaglietta; Amy G Tsai
Journal:  Crit Care       Date:  2008-04-18       Impact factor: 9.097

10.  Can maximum surgical blood order schedule be used as a predictor of successful completion of bloodless surgery?

Authors:  Kyung Il Jo; Jeong Won Shin
Journal:  Ann Lab Med       Date:  2013-02-21       Impact factor: 3.464
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.